E17516Background: The standard treatment approach for ovarian cancer (OC) is a combination of a platinum compound and a taxane, with combination drug therapy reportedly being more effective in the initial treatment of OC compared to monotherapy. The objective of this study was to examine the current treatment patterns for ovarian cancer patients in the US and 5 European countries (EU5) (France, Germany, Italy, Spain, UK) using real world data from Ipsos’ Global Oncology Monitor. Methods: A multi-country, multi-center retrospective medical chart-review of OC patients was conducted by cancer-treating physicians in the US and EU5 between Jul 2016-Jun 2017. Physicians randomly selected patient charts currently on an anti-cancer regimen and abstracted data on patient demographics, disease status, treatment patterns, and biomarker status. Only patients who were diagnosed with Stage III-IV OC were included in the analyses. Results: A total of n = 1,371 (US) and n = 729 (EU5) patients were included in this analys...